Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

10.42
Delayed Data
As of 6:30pm ET
 +0.13 / +1.26%
Today’s Change
6.07
Today|||52-Week Range
22.29
-32.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues19.6B22.0B22.6B18.8B
 
 
 
 
 
Cost of Goods Sold7.0B8.5B9.6B8.7B
 
 
 
 
 
Depreciation And Amortization1.3B1.5B2.1B1.8B
 
 
 
 
 
 
Operating ExpensesGross Income11.3B11.9B10.9B8.3B
 
 
 
 
 
General Expenses6.2B7.2B6.9B5.4B
 
 
 
 
 
Research And Development1.5B2.1B1.9B1.2B
 
 
 
 
 
Total Operating Expenses14.5B17.3B18.5B15.9B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income5.1B4.7B4.0B2.9B
 
 
 
 
 
Extraordinary Credit53.0M----1.5B
 
 
 
Extraordinary Charge-2.4B-3.3B-22.3B-6.1B
 
 
 
 
 
Interest Expense On Debt464.8M692.2M878.8M1.1B
 
 
 
 
 
Equity In Earnings-121.0M8.0M-3.0M-70.8M
 
 
 
 
 
Other Expenses60.0M88.3M515.0M153.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.4B826.6M-18.5B-2.6B
 
 
 
 
 
Income Taxes-633.8M-522.6M-1.9B-194.4M
 
 
 
 
 
Minority Interest-9.0M-18.1M-185.4M-321.0M
 
 
 
 
 
Preferred Dividend-15.0M-261.8M-262.0M-248.2M
 
 
 
 
 
Net Income1.6B330.0M-16.4B-2.1B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS855.0M955.0M1.0B1.0B
 
 
 
 
 
Shares To Calculate EPS Diluted864.0M961.0M1.0B1.0B
 
 
 
 
 
 
Earnings Per ShareEPS$1.84$0.07-$16.39-$2.34
 
 
 
 
 
EPS Diluted$1.82$0.07-$16.39-$2.34